Is Ocugen Stock Heading for a Crash?
Ocugen (NASDAQ: OCGN) shares took center stage earlier this year when the biotech joined the coronavirus vaccine race. The company partnered with India's Bharat Biotech to co-develop and co-commercialize Bharat's vaccine candidate -- Covaxin -- in the U.S. As a result, Ocugen shares soared as much as 763% in about six weeks.
Since the high point reached in February, the stock has retreated 45%. Investors have worried -- and rightly so -- about Covaxin's prospects in the U.S. market. But in recent days, Ocugen shares have begun to pick up speed. They gained more than 22% this past week. Now, some investors might be wondering if Ocugen will hang onto this positive momentum -- or whether the stock is heading for a crash. Let's take a closer look.
Image source: Getty Images.
Source Fool.com
